CD28-SuperMAB
CD28-SuperMAB Uses, Dosage, Side Effects, Food Interaction and all others data.
CD28-SuperMAB is a humanized anti-CD28 monoclonal antibody designed for treating autoimmune diseases and cancer. After the first human trial, it was withdrawn due to severe toxicity (likely due to lymphopenia and human cytokine release).
| Trade Name | CD28-SuperMAB |
| Generic | Theralizumab |
| Theralizumab Other Names | CD28-SuperMAB, Theralizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here CD28-SuperMAB
